Skip to main content

stock

BDPT · BIOADAPTIVES, INC.

What BIOADAPTIVES, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live BDPT price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on BDPT.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
196,926,762 as of 2026-08-13 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
77.4%
Operating
-3557.0%
Net
-4553.2%

Returns

ROE
—
ROA
-1477.6%

Health

Current ratio
0.0x
Debt/equity
—

Deep value

NCAV
-$1.78M
NCAV per share
-$0.01
Price/NCAV
Locked
NNWC
-$1.80M
NNWC per share
-$0.01
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$4,988$4,240-$197,176$150,090
10-Q filed 2026-08-19
2026-03-31$5,514$4,113-$198,218-$111,086
10-Q filed 2026-08-19
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$10,427$7,583-$248,117-$823,346
10-K filed 2026-04-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$4,632$3,851-$265,689-$379,502
10-Q filed 2025-11-14
2025-06-30$3,219$1,063-$279,219-$157,914
10-Q filed 2026-08-19
2025-03-31$0$0-$249,148-$197,136
10-Q filed 2026-08-19
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0$0-$337,339-$371,788
10-K filed 2026-04-14
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$0$0-$121,941-$37,649
10-Q filed 2025-11-14
Assets
$78,767
Equity
-$1.77M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$18,278-$1.04M-$1.56M-$534,025
2024-12-31$12,669-$602,090-$899,161-$249,517
2023-12-31$28,565-$228,921-$712,466—
2022-12-31$17,176-$421,900-$895,570—
2021-12-31$19,776—-$1.05M—
2020-12-31$16,327—-$847,244—
2019-12-31$9,934—-$238,927—
2018-12-31——-$1.41M—
2015-12-31—-$227,276-$227,432—
2014-12-31—-$2.44M-$2.58M-$57,046

Company filings

No 8-K, offering or 5% stake filings in the last year.

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named BDPT, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about BDPT.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about BDPT.

nakagai

Signals on BDPT come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the BDPT board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

BIOADAPTIVES, INC. (BDPT): SEC filings, financials and insider trades · Nakagai